Annual Operating Profit
-$28.47 M
+$10.60 M+27.13%
December 1, 2024
Summary
- As of March 13, 2025, UBX annual operating income is -$28.47 million, with the most recent change of +$10.60 million (+27.13%) on December 1, 2024.
- During the last 3 years, UBX annual operating profit has risen by +$28.20 million (+49.76%).
- UBX annual operating profit is now -51.06% below its all-time high of -$18.84 million, reached on December 31, 2016.
Performance
UBX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$7.29 M
-$684.00 K-10.36%
December 1, 2024
Summary
- As of March 13, 2025, UBX quarterly operating income is -$7.29 million, with the most recent change of -$684.00 thousand (-10.36%) on December 1, 2024.
- Over the past year, UBX quarterly operating profit has dropped by -$684.00 thousand (-10.36%).
- UBX quarterly operating profit is now -10.36% below its all-time high of -$6.60 million, reached on September 30, 2024.
Performance
UBX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$28.47 M
+$391.00 K+1.35%
December 1, 2024
Summary
- As of March 13, 2025, UBX TTM operating income is -$28.47 million, with the most recent change of +$391.00 thousand (+1.35%) on December 1, 2024.
- Over the past year, UBX TTM operating profit has increased by +$391.00 thousand (+1.35%).
- UBX TTM operating profit is now -214.89% below its all-time high of -$9.04 million, reached on March 31, 2017.
Performance
UBX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
UBX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.1% | -10.4% | +1.4% |
| 3 y3 years | +49.8% | +47.6% | +50.6% |
| 5 y5 years | +68.7% | +47.6% | +50.6% |
UBX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.6% | -10.4% | +60.1% | at high | +52.5% |
| 5 y | 5-year | at high | +68.8% | -10.4% | +71.3% | at high | +70.4% |
| alltime | all time | -51.1% | +68.8% | -10.4% | +71.3% | -214.9% | +70.4% |
Unity Biotechnology Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$28.47 M(-27.1%) | -$7.29 M(+10.4%) | -$28.47 M(-1.4%) |
| Sep 2024 | - | -$6.60 M(-5.4%) | -$28.86 M(-7.6%) |
| Jun 2024 | - | -$6.98 M(-8.2%) | -$31.23 M(-13.5%) |
| Mar 2024 | - | -$7.60 M(-1.0%) | -$36.10 M(-7.6%) |
| Dec 2023 | -$39.06 M(-32.1%) | -$7.68 M(-14.5%) | -$39.06 M(-13.8%) |
| Sep 2023 | - | -$8.98 M(-24.2%) | -$45.30 M(-8.4%) |
| Jun 2023 | - | -$11.85 M(+12.2%) | -$49.45 M(-0.8%) |
| Mar 2023 | - | -$10.56 M(-24.1%) | -$49.86 M(-13.4%) |
| Dec 2022 | -$57.57 M(+1.6%) | -$13.92 M(+6.0%) | -$57.57 M(+7.5%) |
| Sep 2022 | - | -$13.13 M(+7.1%) | -$53.55 M(-3.1%) |
| Jun 2022 | - | -$12.26 M(-32.9%) | -$55.25 M(-7.9%) |
| Mar 2022 | - | -$18.27 M(+84.6%) | -$59.99 M(+5.9%) |
| Dec 2021 | -$56.66 M(-38.0%) | -$9.90 M(-33.2%) | -$56.66 M(-12.9%) |
| Sep 2021 | - | -$14.83 M(-12.8%) | -$65.08 M(-13.9%) |
| Jun 2021 | - | -$17.00 M(+13.7%) | -$75.61 M(-6.7%) |
| Mar 2021 | - | -$14.94 M(-18.4%) | -$81.06 M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$91.33 M(+0.4%) | -$18.31 M(-27.8%) | -$91.33 M(-5.0%) |
| Sep 2020 | - | -$25.36 M(+13.0%) | -$96.14 M(+2.0%) |
| Jun 2020 | - | -$22.44 M(-11.0%) | -$94.24 M(-1.0%) |
| Mar 2020 | - | -$25.22 M(+9.1%) | -$95.24 M(+4.7%) |
| Dec 2019 | -$91.00 M(+21.5%) | -$23.11 M(-1.5%) | -$91.00 M(+2.8%) |
| Sep 2019 | - | -$23.47 M(+0.1%) | -$88.55 M(+5.6%) |
| Jun 2019 | - | -$23.44 M(+11.7%) | -$83.82 M(+5.5%) |
| Mar 2019 | - | -$20.98 M(+1.6%) | -$79.42 M(+6.0%) |
| Dec 2018 | -$74.92 M(+64.3%) | -$20.66 M(+10.2%) | -$74.92 M(+11.7%) |
| Sep 2018 | - | -$18.74 M(-1.6%) | -$67.05 M(+11.0%) |
| Jun 2018 | - | -$19.04 M(+15.5%) | -$60.39 M(+13.8%) |
| Mar 2018 | - | -$16.48 M(+28.9%) | -$53.05 M(+16.3%) |
| Dec 2017 | -$45.61 M(+142.0%) | -$12.79 M(+5.8%) | -$45.61 M(+39.0%) |
| Sep 2017 | - | -$12.08 M(+3.3%) | -$32.82 M(+58.3%) |
| Jun 2017 | - | -$11.70 M(+29.4%) | -$20.74 M(+129.4%) |
| Mar 2017 | - | -$9.04 M | -$9.04 M |
| Dec 2016 | -$18.84 M | - | - |
FAQ
- What is Unity Biotechnology annual operating income?
- What is the all time high annual operating profit for Unity Biotechnology?
- What is Unity Biotechnology annual operating profit year-on-year change?
- What is Unity Biotechnology quarterly operating income?
- What is the all time high quarterly operating profit for Unity Biotechnology?
- What is Unity Biotechnology quarterly operating profit year-on-year change?
- What is Unity Biotechnology TTM operating income?
- What is the all time high TTM operating profit for Unity Biotechnology?
- What is Unity Biotechnology TTM operating profit year-on-year change?
What is Unity Biotechnology annual operating income?
The current annual operating profit of UBX is -$28.47 M
What is the all time high annual operating profit for Unity Biotechnology?
Unity Biotechnology all-time high annual operating income is -$18.84 M
What is Unity Biotechnology annual operating profit year-on-year change?
Over the past year, UBX annual operating income has changed by +$10.60 M (+27.13%)
What is Unity Biotechnology quarterly operating income?
The current quarterly operating profit of UBX is -$7.29 M
What is the all time high quarterly operating profit for Unity Biotechnology?
Unity Biotechnology all-time high quarterly operating income is -$6.60 M
What is Unity Biotechnology quarterly operating profit year-on-year change?
Over the past year, UBX quarterly operating income has changed by -$684.00 K (-10.36%)
What is Unity Biotechnology TTM operating income?
The current TTM operating profit of UBX is -$28.47 M
What is the all time high TTM operating profit for Unity Biotechnology?
Unity Biotechnology all-time high TTM operating income is -$9.04 M
What is Unity Biotechnology TTM operating profit year-on-year change?
Over the past year, UBX TTM operating income has changed by +$391.00 K (+1.35%)